Influenza virus vaccine 2021-2022 (quadrivalent Tasmania/Washington/Darwin/Singapore) 0.5 mL Injectable Suspension
RxNorm 2562997

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2562997 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: influenza virus vaccine 2021-2022 (quadrivalent Tasmania/Washington/Darwin/Singapore) 0.5 mL Injectable Suspension.

The following semantic concepts and normalized strings are associated with this clinical entity:

SCD
Influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 mg/ML / influenza A virus A/Washington/19/2020 (H1N1) antigen 0.03 mg/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 mg/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 mg/ML Injectable Suspension
Primary clinical definition
AUI:12656869
PSN
Influenza virus vaccine 2021-2022 (quadrivalent Tasmania/Washington/Darwin/Singapore) 0.5 mL Injectable Suspension
AUI:12658049
SY
Influenza virus vaccine 2021-2022 (quadrivalent Tasmania/Washington/Darwin/Singapore) 0.5 mL Injectable Suspension
AUI:12658050

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SCD

Semantic Clinical Drug (SCD):
Influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 mg/ML / influenza A virus A/Washington/19/2020 (H1N1) antigen 0.03 mg/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 mg/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 mg/ML Injectable Suspension
(Atom ID: 12656869)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Washington/19/2020 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Injectable Suspension
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2562997
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12656869
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SCD
Semantic Clinical Drug (Ingredient + Strength + Dose Form)
Source Code
2562997
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{2056526} 2056525
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{2380841} 2380838
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{2561272} 2561244
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{2563001} 2562554
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{2056526} 2056525
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{2380841} 2380838
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{2561272} 2561244
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{2563001} 2562554
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{2056526} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{2380841} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{2561272} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{2563001} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN OBSOLETED
07/01/2025
Date the RxNorm atom became obsolete
RXTERM FORM
Susp
The RxTerm dose form name for this drug

PSN

Prescribable Name (PSN):
Influenza virus vaccine 2021-2022 (quadrivalent Tasmania/Washington/Darwin/Singapore) 0.5 mL Injectable Suspension
(Atom ID: 12658049)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
influenza virus vaccine 2021-2022 (quadrivalent Tasmania/Washington/Darwin/Singapore) 0.5 mL Injectable Suspension
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2562997
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12658049
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
2562997
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

SY

Synonym (SY):
Influenza virus vaccine 2021-2022 (quadrivalent Tasmania/Washington/Darwin/Singapore) 0.5 mL Injectable Suspension
(Atom ID: 12658050)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
influenza virus vaccine 2021-2022 (quadrivalent Tasmania/Washington/Darwin/Singapore) 0.5 ML Injectable Suspension
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2562997
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12658050
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
2562997
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.